This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

SYST-EUR study

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

This study tests the efficacy of using a calcium channel blocker in elderly patients with isolated systemic hypertension. The study involves 4,695 patients from 198 centres in Europe. Participants in the trial were randomised to nitrendipine or placebo; enalapril or hydrochlorthiazide could be added if required - however most patients on nitrendipine remained on monotherapy during the study.

The use of nitrendipine cut the risk of stroke by 42% compared with placebo. There were also reductions in risk of cardiovascular events (fatal and non-fatal) by 29%, for fatal MI (56%). There was a non-significant reduction (14%) in all-cause mortality.

Reference:

  • Medical Monitor (3/9/97), 3.

Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.